Trial · NCT01043185
Participant flow210
How many started, completed or left each group, period by period.
61 to 80 of 210
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 3 - Second Intervention | STARTED | First 30mg, Then 90mg, Then 120mg, Then Placebo | 3 | |
| Period 3 - Second Intervention | STARTED | First 30mg, Then 90mg, Then Placebo, Then 120mg | 2 | |
| Period 3 - Second Intervention | STARTED | First 120mg, Then Placebo, Then 240mg, Then 90mg | 3 | |
| Period 3 - Second Intervention | STARTED | First Placebo, Then 30mg, Then 90mg, Then 120mg | 2 | |
| Period 3 - Second Intervention | STARTED | First 90mg, Then Placebo, Then 120mg, Then 240mg | 2 | |
| Period 3 - Second Intervention | STARTED | First Placebo, Then 240mg, Then 90mg, Then 30mg | 3 | |
| Period 3 - Second Intervention | STARTED | First 90mg, Then 120mg, Then Placebo, Then 240mg | 3 | |
| Period 3 - Second Intervention | STARTED | First 120mg, Then 30mg, Then 240mg, Then Placebo | 3 | |
| Period 3 - Second Intervention | STARTED | First 240mg, Then 30mg, Then 90mg, Then Placebo | 3 | |
| Period 3 - Second Intervention | STARTED | First Placebo, Then 120mg, Then 30mg, Then 240mg | 3 | |
| Period 3 - Second Intervention | COMPLETED | First 30mg, Then 90mg, Then 120mg, Then Placebo | 3 | |
| Period 3 - Second Intervention | COMPLETED | First 30mg, Then 90mg, Then Placebo, Then 120mg | 2 | |
| Period 3 - Second Intervention | COMPLETED | First 120mg, Then Placebo, Then 240mg, Then 90mg | 3 | |
| Period 3 - Second Intervention | COMPLETED | First Placebo, Then 30mg, Then 90mg, Then 120mg | 2 | |
| Period 3 - Second Intervention | COMPLETED | First 90mg, Then Placebo, Then 120mg, Then 240mg | 2 | |
| Period 3 - Second Intervention | COMPLETED | First Placebo, Then 240mg, Then 90mg, Then 30mg | 3 | |
| Period 3 - Second Intervention | COMPLETED | First 90mg, Then 120mg, Then Placebo, Then 240mg | 3 | |
| Period 3 - Second Intervention | COMPLETED | First 120mg, Then 30mg, Then 240mg, Then Placebo | 3 | |
| Period 3 - Second Intervention | COMPLETED | First 240mg, Then 30mg, Then 90mg, Then Placebo | 3 | |
| Period 3 - Second Intervention | COMPLETED | First Placebo, Then 120mg, Then 30mg, Then 240mg | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01043185/flow?page=4